LORELEI SALAZAR: Open Payments
NPI 1972733236 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,901 in 23 payments from 8 companies in 2025. Trend: 2023 $90 · 2024 $247 · 2025 $5,901
Consulting: $3,240Food & beverage: $1,382Travel & lodging: $1,278
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $4,861 |
| GENZYME CORPORATION | 4 | $465 |
| Alexion Pharmaceuticals, Inc. | 2 | $247 |
| Biogen, Inc. | 2 | $109 |
| Novartis Pharmaceuticals Corporation | 1 | $76 |
| UCB, Inc. | 1 | $75 |
| EMD Serono, Inc. | 1 | $35 |
| TG Therapeutics, Inc. | 1 | $33 |
Products named: UPLIZNA, TYSABRI, KESIMPTA, BRIUMVI, QALSODY.
Industry payments across TX — which companies pay providers there.
